Detalles de la búsqueda
1.
Mortality risk in patients with autosomal dominant polycystic kidney disease.
BMC Nephrol
; 25(1): 56, 2024 Feb 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-38365638
2.
The Zero-Price Conundrum: Exploration of Scenarios Where a Clinically Effective New Drug Might Not Be Cost-Effective at Zero Price.
Value Health
; 26(3): 384-391, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36706950
3.
A disease progression model estimating the benefit of tolvaptan on time to end-stage renal disease for patients with rapidly progressing autosomal dominant polycystic kidney disease.
BMC Nephrol
; 23(1): 334, 2022 10 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-36258169
4.
A framework for assessing the lifetime economic burden of congenital cytomegalovirus in the United States.
Cost Eff Resour Alloc
; 17: 21, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31592087
5.
Cost-Effectiveness of Lovotibeglogene Autotemcel (Lovo-Cel) Gene Therapy for Patients with Sickle Cell Disease and Recurrent Vaso-Occlusive Events in the United States.
Pharmacoeconomics
; 42(6): 693-714, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38684631
6.
The faces of personalized medicine: a framework for understanding its meaning and scope.
Value Health
; 16(6 Suppl): S4-9, 2013.
Artículo
en Inglés
| MEDLINE | ID: mdl-24034312
7.
A post hoc analysis of Projected Retained Ability Scores (PRAS) for the longitudinal assessment of cognitive functioning in patients with neuronopathic mucopolysaccharidosis II receiving intrathecal idursulfase-IT.
Orphanet J Rare Dis
; 18(1): 343, 2023 Nov 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-37915038
8.
The evolution of ICER's review process for new medical interventions and a critical review of economic evaluations (2018-2019): how stakeholders can collaborate with ICER to improve the quality of evidence in ICER's reports.
J Manag Care Spec Pharm
; 27(11): 1601-1612, 2021 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-34714108
9.
Cost- Effectiveness of Avatrombopag for the Treatment of Thrombocytopenia in Patients with Chronic Liver Disease.
Clinicoecon Outcomes Res
; 12: 515-526, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32982341
10.
US Budget Impact Model for Selinexor in Relapsed or Refractory Multiple Myeloma.
Clinicoecon Outcomes Res
; 12: 317-325, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32606848
11.
The Humanistic and Economic Burden of Chronic Idiopathic Constipation in the USA: A Systematic Literature Review.
Clin Exp Gastroenterol
; 13: 255-265, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32765039
12.
Value of clinical trial narrative data to estimate the costs of adverse event management: a feasibility study.
J Med Econ
; 23(3): 213-220, 2020 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-31595803
13.
Cost estimate of platelet transfusion in the United States for patients with chronic liver disease and associated thrombocytopenia undergoing elective procedures.
J Med Econ
; 21(8): 827-834, 2018 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-29912593
14.
Expected Budget Impact and Health Outcomes of Expanded Use of Vagus Nerve Stimulation Therapy for Drug-Resistant Epilepsy.
Adv Ther
; 35(10): 1686-1696, 2018 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-30143957
15.
Correction to: Expected Budget Impact and Health Outcomes of Expanded Use of Vagus Nerve Stimulation Therapy for Drug-Resistant Epilepsy.
Adv Ther
; 35(10): 1697, 2018 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-30209749
16.
An economic analysis of tolvaptan compared with fluid restriction among hospitalized patients with hyponatremia.
Hosp Pract (1995)
; 45(3): 111-117, 2017 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-28449624
17.
A Matching-Adjusted Indirect Comparison of Sonidegib and Vismodegib in Advanced Basal Cell Carcinoma.
J Skin Cancer
; 2017: 6121760, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28607774
18.
Cost-effectiveness analysis of universal noninvasive testing for post-treatment confirmation of Helicobacter pylori eradication and the impact of patient adherence.
Patient Prefer Adherence
; 10: 1025-35, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-27354772
19.
Impact of patient adherence on the cost-effectiveness of noninvasive tests for the initial diagnosis of Helicobacter pylori infection in the United States.
Patient Prefer Adherence
; 10: 45-55, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-26855566
20.
Cost-effectiveness of Low-dose Submicron Diclofenac Compared With Generic Diclofenac.
Clin Ther
; 38(11): 2418-2429, 2016 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-27793353